These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


136 related items for PubMed ID: 4302083

  • 21. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens.
    Longstreth JD, Ihle JN, Hanna MG.
    Ann N Y Acad Sci; 1976; 276():343-57. PubMed ID: 68698
    [No Abstract] [Full Text] [Related]

  • 22. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR, Nowinski RC, Henney CS.
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract] [Full Text] [Related]

  • 23. Murine-leukemia-virus-related cell-surface antigens as serological markers of AKR ecotropic, xenotropic, and dualtropic viruses.
    O'Donnell PV, Stockert E, Obata Y, DeLeo AB, Old LJ.
    Cold Spring Harb Symp Quant Biol; 1980 Aug; 44 Pt 2,():1255-64. PubMed ID: 6253199
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. AKR-MuLV-associated cell surface antigens.
    Ihle JN, Longstreth JD, Pazmiño NH, McLellan WL, Hanna MG.
    Med Microbiol Immunol; 1977 Aug; 164(1-3):179-95. PubMed ID: 202850
    [No Abstract] [Full Text] [Related]

  • 26. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR, Nowinski RC, Henney CS.
    J Exp Med; 1979 Jul 01; 150(1):51-66. PubMed ID: 109575
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The structural proteins of murine leukemia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in SL/Ni mice.
    Yoshiki T, Hayasaka T, Fukatsu R, Shirai T, Itoh T, Ikeda H, Katagiri M.
    J Immunol; 1979 May 01; 122(5):1812-20. PubMed ID: 221579
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of a rapidly growing AKR lymphoblastic cell line maintaining Gross antigens and viral replication.
    Woods WA, Wivel NA, Massicot JG, Chirigos MA.
    Cancer Res; 1970 Aug 01; 30(8):2147-55. PubMed ID: 4918189
    [No Abstract] [Full Text] [Related]

  • 30. Virion and non-virion murine leukemia membrane antigens: analysis with virus-absorbed antisera.
    Moroni C, Robert-Guroff M, Martin D.
    Intervirology; 1974 Aug 01; 3(5-6):292-304. PubMed ID: 4443190
    [No Abstract] [Full Text] [Related]

  • 31. Wild-type Gross leukemia virus. I. Soluble antigen (GSA) in the plasma and tissues of infected mice.
    Aoki T, Boyse EA, Old LJ.
    J Natl Cancer Inst; 1968 Jul 01; 41(1):89-96. PubMed ID: 4880891
    [No Abstract] [Full Text] [Related]

  • 32. Study of the antigenic specificity of Graffi leukemic cells.
    Levy JP, Leclerc JC, Varet B, Oppenheim E.
    J Natl Cancer Inst; 1968 Sep 01; 41(3):743-50. PubMed ID: 4300309
    [No Abstract] [Full Text] [Related]

  • 33. Alteration of skin in Gross leukemia. 3. Quantitation of the role of tumor cells.
    Mariani T, Maruyama Y, Good RA.
    J Natl Cancer Inst; 1972 Feb 01; 48(2):363-6. PubMed ID: 4568966
    [No Abstract] [Full Text] [Related]

  • 34. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen.
    Gerlier D, Bakouche O, Dore JF.
    J Immunol; 1983 Jul 01; 131(1):485-90. PubMed ID: 6190925
    [No Abstract] [Full Text] [Related]

  • 35. The humoral immune response of NIH Swiss and SWR/J mice to vaccination with formalinized AKR or Gross murine leukemia virus.
    Lee JC, Ihle JN, Huebner R.
    Proc Natl Acad Sci U S A; 1977 Jan 01; 74(1):343-7. PubMed ID: 189311
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Evidence of viral implication in experimental leukemia induced by n-nitrosobutylurea in mice.
    Imamura N.
    Gan; 1973 Feb 01; 64(1):47-57. PubMed ID: 4718409
    [No Abstract] [Full Text] [Related]

  • 38. Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.
    Barnes RD, Tuffrey M, Holliday J, Hilgers JH, Souissi T.
    Br J Cancer; 1976 Jul 01; 34(1):28-38. PubMed ID: 182191
    [Abstract] [Full Text] [Related]

  • 39. Impaired generation of anti-AKR/Gross murine leukemia virus cytotoxic T lymphocytes in mice experimentally infected with MuLV.
    Coppola MA, Green WR, Rich RF.
    Viral Immunol; 1996 Jul 01; 9(2):107-19. PubMed ID: 8822627
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.